1. Home
  2. LXRX vs RDVT Comparison

LXRX vs RDVT Comparison

Compare LXRX & RDVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LXRX

Lexicon Pharmaceuticals Inc.

SELL

Current Price

$1.79

Market Cap

996.7M

Sector

Health Care

ML Signal

SELL

Logo Red Violet Inc.

RDVT

Red Violet Inc.

SELL

Current Price

$69.30

Market Cap

1.1B

Sector

Technology

ML Signal

SELL

Company Overview

Basic Information
Metric
LXRX
RDVT
Founded
1995
2017
Country
United States
United States
Employees
N/A
250
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
996.7M
1.1B
IPO Year
2000
2017

Fundamental Metrics

Financial Performance
Metric
LXRX
RDVT
Price
$1.79
$69.30
Analyst Decision
Buy
Buy
Analyst Count
6
4
Target Price
$4.52
★ $97.00
AVG Volume (30 Days)
★ 2.0M
151.4K
Earning Date
11-05-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
77.78
★ 82.00
EPS
N/A
★ 0.99
Revenue
$49,803,000.00
★ $90,252,000.00
Revenue This Year
N/A
$19.00
Revenue Next Year
N/A
$14.07
P/E Ratio
★ N/A
$72.09
Revenue Growth
★ 60.24
20.03
52 Week Low
$1.10
$33.40
52 Week High
$2.68
$83.15

Technical Indicators

Market Signals
Indicator
LXRX
RDVT
Relative Strength Index (RSI) 57.67 36.88
Support Level $1.48 $64.15
Resistance Level $1.96 $71.68
Average True Range (ATR) 0.11 3.71
MACD 0.04 -0.76
Stochastic Oscillator 70.65 34.34

Price Performance

Historical Comparison
LXRX
RDVT

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

About RDVT Red Violet Inc.

Red Violet Inc builds proprietary technologies and applies analytical capabilities to deliver identity intelligence. The company's solutions enable the real-time identification and location of people, businesses, assets, and their interrelationships. These solutions are used for purposes including identity verification, risk mitigation, due diligence, fraud detection and prevention, regulatory compliance, and customer acquisition. Its cloud-native, AI-enabled identity intelligence platform, CORE, is purpose-built for the enterprise, yet flexible enough for organizations of all sizes, bringing clarity to massive datasets by transforming data into intelligence. The company generates substantially all of its revenue from licensing its solutions.

Share on Social Networks: